Published in Eur J Immunol on September 01, 1995
In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci U S A (2003) 4.18
Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J Exp Med (2002) 3.94
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest (2001) 3.79
Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med (1999) 2.33
Interleukin-2 enhances CD4+ T cell memory by promoting the generation of IL-7R alpha-expressing cells. J Exp Med (2007) 1.99
Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med (2004) 1.89
A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J Exp Med (1998) 1.84
Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J Exp Med (1995) 1.70
The future of interleukin-2: enhancing therapeutic anticancer vaccines. Cancer J Sci Am (2000) 1.52
Interleukin 2: from immunostimulation to immunoregulation and back again. EMBO Rep (2007) 1.31
Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus. J Clin Invest (1999) 1.21
The quantal theory of how the immune system discriminates between "self and non-self" Med Immunol (2004) 1.13
Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo. J Exp Med (1999) 1.10
The power and the promise of restimulation-induced cell death in human immune diseases. Immunol Rev (2010) 1.09
Functional dissection of the cytoplasmic subregions of the IL-2 receptor betac chain in primary lymphocyte populations. EMBO J (1998) 1.08
The interleukin 2 receptor alpha chain/CD25 promoter is a target for nuclear factor of activated T cells. J Exp Med (1998) 1.07
CD4+ T cell-derived IL-2 signals during early priming advances primary CD8+ T cell responses. PLoS One (2009) 0.93
Homeostatic T cell proliferation as a barrier to T cell tolerance. Philos Trans R Soc Lond B Biol Sci (2005) 0.91
Nonsegmental vitiligo and autoimmune mechanism. Dermatol Res Pract (2011) 0.89
Disrupted B-lymphocyte development and survival in interleukin-2-deficient mice. Immunology (2001) 0.87
A role for the Tec family kinase ITK in regulating SEB-induced interleukin-2 production in vivo via c-jun phosphorylation. BMC Immunol (2005) 0.83
Gamma chain receptor interleukins: evidence for positive selection driving the evolution of cell-to-cell communicators in the mammalian immune system. J Mol Evol (2005) 0.82
Nasal delivery of antigen with the B subunit of Escherichia coli heat-labile enterotoxin augments antigen-specific T-cell clonal expansion and differentiation. Infect Immun (2004) 0.82
Protective roles of alpha-calcitonin and beta-calcitonin gene-related peptide in spontaneous and experimentally induced colitis. Dig Dis Sci (2007) 0.82
Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD mice. PLoS One (2011) 0.80
Methods for optimizing statistical analyses in pharmacogenomics research. Expert Rev Clin Pharmacol (2009) 0.79
Impaired B cell responses to orally administered antigens in lamina propria but not Peyer's patches of Galphai2-deficient mice prior to colitis. Immunology (2005) 0.78
The characterization of testicular cell (TC)-specific T-cell clones induced by intratesticular Listeria monocytogenes infection: TC-specific T cells with atypical cytokine profile transfer orchitis. Immunology (1997) 0.77
Clonal expansion of superantigen-reactive T cells is resistant to FK506 in mice with AIDS. J Virol (1997) 0.75
Manipulating IL-2 availability amid presentation of donor MHC antigens suppresses murine alloimmune responses by inducing regulatory T cells. PLoS One (2010) 0.75
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell (1993) 11.95
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell (1991) 10.96
Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature (1991) 5.51
Replacement of T-cell function by a T-cell product. Nat New Biol (1972) 5.20
The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol (1992) 3.66
The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature (1999) 3.65
Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin- mediated cell-cell adhesion. Science (1998) 3.39
Cloning of an interleukin-3 receptor gene: a member of a distinct receptor gene family. Science (1990) 3.35
Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol (1992) 2.83
Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol (1996) 2.58
Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation. J Biol Chem (2000) 2.50
Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol (2001) 2.39
DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol (1992) 2.37
MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J Biol Chem (2001) 2.32
Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2007) 2.25
A third signal in B cell activation given by TRF. Transplant Rev (1975) 2.18
Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci U S A (1994) 2.04
Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res (1994) 1.90
Cloning and expression of a gene encoding an interleukin 3 receptor-like protein: identification of another member of the cytokine receptor gene family. Proc Natl Acad Sci U S A (1990) 1.85
Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem (2000) 1.76
Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med (1998) 1.74
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology (1998) 1.73
Cdc42 and Rac1 regulate the interaction of IQGAP1 with beta-catenin. J Biol Chem (1999) 1.72
Proteolytic activation of MST/Krs, STE20-related protein kinase, by caspase during apoptosis. Oncogene (1998) 1.70
Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J Exp Med (1995) 1.70
Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci U S A (1990) 1.68
Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci U S A (1995) 1.62
Cytotoxicity of fresh NK1.1+ T cell receptor alpha/beta+ thymocytes against a CD4+8+ thymocyte population associated with intact Fas antigen expression on the target. J Exp Med (1994) 1.60
NMR structure of the calreticulin P-domain. Proc Natl Acad Sci U S A (2001) 1.58
Ex vivo whole-embryo culture of caspase-8-deficient embryos normalize their aberrant phenotypes in the developing neural tube and heart. Cell Death Differ (2002) 1.56
Stimulation of IgG antibody response in vitro by T cell-replacing factor. J Exp Med (1973) 1.55
Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms. Eur J Immunol (2001) 1.55
The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J Exp Med (1997) 1.55
Inhibition of in vitro immune response by treatment of spleen cell suspensions with anti-theta serum. Nature (1970) 1.53
Quantification of late complications after radiation therapy. Radiother Oncol (2001) 1.50
Reconstitution of a thymus cell-deprived immune system by syngeneic and allogeneic thymocytes in vitro. Eur J Immunol (1971) 1.47
The E1b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. Int Immunol (1991) 1.45
Cyanamide Formation under Primitive Earth Conditions. Science (1965) 1.42
Late bone and soft tissue sequelae of childhood radiotherapy. Relevance of treatment age and radiation dose in 146 children treated between 1970 and 1997. Strahlenther Onkol (2013) 1.40
Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J Immunol (1991) 1.40
Late complications after a combined pre and postoperative (sandwich) radiotherapy for rectal cancer. Radiother Oncol (1999) 1.40
Expression and function of mouse Fas antigen on immature and mature T cells. J Immunol (1995) 1.38
Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J Invest Dermatol (1994) 1.36
RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J (1995) 1.34
The differentiation function of T cell-replacing factor in nu-nu spleen cell cultures. Eur J Immunol (1974) 1.33
IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med (1994) 1.30
A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells. J Immunol (1991) 1.29
Binding of human interferon alpha to cells of different sensitivities: studies with internally radiolabeled interferon retaining full biological activity. J Virol (1983) 1.28
Different binding of human interferon alpha 1 and alpha 2 to common receptors on human and bovine cells. Studies with recombination interferons produced in Escherichia coli. J Biol Chem (1983) 1.24
Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC). Radiother Oncol (2011) 1.24
Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8. Oncogene (1997) 1.23
Duodenal gangliocytic paraganglioma with lymph node metastasis in a 17-year-old boy. Cancer (1989) 1.22
ER stress induces caspase-8 activation, stimulating cytochrome c release and caspase-9 activation. Exp Cell Res (2003) 1.21
A new concept of cellular uptake and intracellular trafficking of long-chain fatty acids. Lipids (2001) 1.21
Autoradiographic studies on the proliferation of antibody-producing cells in vitro. J Exp Med (1974) 1.20
Partial characterization and purification of murine T cell-replacing factor, TRF. II. Biochemical characteristics. Immunochemistry (1978) 1.20
Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice. J Clin Invest (1996) 1.19
Production of interleukin 3 and gamma-interferon by an antigen-specific mouse suppressor T cell clone. J Immunol (1985) 1.19
Tumor necrosis factor amplifies measles virus-mediated Ia induction on astrocytes. Proc Natl Acad Sci U S A (1987) 1.18
Expression of MuLV GP71-like antigen in normal mouse spleen cells induced by antigenic stimulation. Nature (1977) 1.18
Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP. Cell Death Differ (2005) 1.17
Rapid acceleration of neutrophil apoptosis by tumor necrosis factor-alpha. Int Immunol (1993) 1.16
Thymic metastasis from prostatic carcinoma: report of a case. Surg Today (1993) 1.16
Studies on the generation and expression of H-2-controlled T helper function in chimeric mice: evidence for two levels of H-2 resitriction. Eur J Immunol (1979) 1.16
Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol (1997) 1.15
Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Am J Gastroenterol (2000) 1.14
Redox regulation of caspase-3(-like) protease activity: regulatory roles of thioredoxin and cytochrome c. J Immunol (1998) 1.13
LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria. J Immunol (2001) 1.10
Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor. Eur J Immunol (1991) 1.09
Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses. Mucosal Immunol (2008) 1.08
Retarded thymic involution and massive germinal center formation in NF-ATp-deficient mice. Eur J Immunol (1998) 1.07
The interleukin 2 receptor alpha chain/CD25 promoter is a target for nuclear factor of activated T cells. J Exp Med (1998) 1.07
Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-mu F(ab')2-co-stimulated B lymphocytes. Eur J Immunol (1996) 1.07
Action of dextran sulfate as a direct and general B cell mitogen. Eur J Immunol (1974) 1.07
Anti-Fas IgG1 antibodies recognizing the same epitope of Fas/APO-1 mediate different biological effects in vitro. Int Immunol (1997) 1.06
Inducible nuclear factors binding the IgM heavy chain pre-mRNA secretory poly(A) site. Eur J Immunol (1996) 1.05
Downregulation of HLA class I antigens in HIV-1-infected cells. AIDS Res Hum Retroviruses (1989) 1.05
IL-5 receptor positive B cells, but not eosinophils, are functionally and numerically influenced in mice carrying the X-linked immune defect. Int Immunol (1993) 1.04
Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J Exp Med (1997) 1.04
Peripheral T-cell reactivity to bacterial superantigens in vivo: the response/anergy paradox. Immunol Rev (1993) 1.04
Novel cell death by downregulation of eEF1A1 expression in tetraploids. Cell Death Differ (2008) 1.02
Differential effects on expression of IL-2 receptors (p55 and p70) by the HTLV-I pX DNA. Int J Cancer (1988) 1.02
Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group. Ann Oncol (2008) 1.02
CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB. J Immunol (1996) 1.01
NF-ATp plays a prominent role in the transcriptional induction of Th2-type lymphokines. Immunol Lett (1997) 1.01
Stimulation of murine B cells with anti-Ig antibodies: dominance of a negative signal mediated by the Fc receptor. Eur J Immunol (1980) 1.00
A1 expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti-IgM-induced cell death. Eur J Immunol (1999) 1.00
Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression. Eur J Immunol (1987) 1.00
In vivo analysis of Fas antigen-mediated apoptosis: effects of agonistic anti-mouse Fas mAb on thymus, spleen and liver. Int Immunol (1997) 0.99
Purification, molecular cloning, and characterization of TRP32, a novel thioredoxin-related mammalian protein of 32 kDa. J Biol Chem (1998) 0.99
NMR structure and metal interactions of the CopZ copper chaperone. J Biol Chem (1999) 0.99
Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells. Eur J Immunol (1997) 0.98
Transcriptional control of mu- and kappa-gene expression in resting and bacterial lipopolysaccharide-activated normal B cells. Immunobiology (1987) 0.98
HJV gene mutations in European patients with juvenile hemochromatosis. Clin Genet (2005) 0.98
Thymic selection and peptide-induced activation of T cell receptor-transgenic CD8 T cells in interleukin-2-deficient mice. Eur J Immunol (1994) 0.97